SEC Company Response from Jazz Pharmaceuticals plc (JAZZ) (CIK 0001232524) (JAZZ) — Jan 6, 2015
Jazz Pharmaceuticals plc (JAZZ) (CIK 0001232524)
Date: Jan. 6, 2015 · CIK: 0001232524 · Accession: 0001193125-15-002928
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-33500
Referenced dates: December 22, 2014
Letter
Via EDGAR Division of Corporate Finance Filed February 25, 2014 Form 10-Q for the Quarterly Period Ended September 30, 2014 Filed November 4, 2014 File No. 001-33500
Dear Mr. Rosenberg:
On behalf of Jazz Pharmaceuticals plc (the “Company”), this letter is being transmitted to inform the staff of the Securities and Exchange Commission (the “Staff”) that the Company intends to respond to the Staff’s letter dated December 22, 2014 regarding the Staff’s review of the above-referenced filings no later than January 20, 2015.
Please do not hesitate to contact me at (650) 496-2654 if you have any questions or would like additional information regarding this matter.
Sincerely,
/s/ Karen J. Wilson
Show Raw Text
CORRESP 1 filename1.htm Correspondence January 6, 2015 Via EDGAR Mr. Jim B. Rosenberg Senior Assistant Chief Accountant U.S. Securities and Exchange Commission Division of Corporate Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Jazz Pharmaceuticals plc Form 10-K for the Fiscal Year Ended December 31, 2013 Filed February 25, 2014 Form 10-Q for the Quarterly Period Ended September 30, 2014 Filed November 4, 2014 File No. 001-33500 Dear Mr. Rosenberg: On behalf of Jazz Pharmaceuticals plc (the “Company”), this letter is being transmitted to inform the staff of the Securities and Exchange Commission (the “Staff”) that the Company intends to respond to the Staff’s letter dated December 22, 2014 regarding the Staff’s review of the above-referenced filings no later than January 20, 2015. Please do not hesitate to contact me at (650) 496-2654 if you have any questions or would like additional information regarding this matter. Sincerely, /s/ Karen J. Wilson Karen J. Wilson Senior Vice President, Finance and Principal Accounting Officer Jazz Pharmaceuticals plc cc: Matthew P. Young, Jazz Pharmaceuticals plc Suzanne Sawochka Hooper, Jazz Pharmaceuticals plc Chadwick Mills, Cooley LLP